Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

XML

Clinical/translational cancer immunotherapy

Original research

Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes

Online download statistics by month:

Online download statistics by month: January 2021 to May 2022

	Abstract	Full	Pdf
Jan 2021	629	632	219
Feb 2021	267	268	76
Mar 2021	298	298	114
Apr 2021	240	240	56
May 2021	162	162	59
Jun 2021	231	231	70
Jul 2021	203	203	33
Aug 2021	226	226	77
Sep 2021	153	153	68
Oct 2021	191	191	77
Nov 2021	205	206	87
Dec 2021	216	219	66
Jan 2022	192	195	117
Feb 2022	229	232	110
Mar 2022	179	179	114
Apr 2022	300	305	123
May 2022	235	240	130
Total	4156	4180	1596